Protein Extrusion and Postprandial Amino Acid Handling

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

9 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-02-02

Study Completion Date

2023-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The bulk of research that has investigated the effect of dietary protein on muscle tissue in humans has used isolated, minimally processed protein powders. However, the protein that we consume on a daily basis has typically undergone various processing methods, and evidence suggests these can change the way our bodies metabolise the protein. 'Extrusion' is a common processing method that uses high pressure to produce protein containing cereals and meat replacement foods. There is currently no research looking at how extrusion affects the way a protein source is digested and absorbed in humans. This study will compare the availability of ingested protein in the blood in the hours following consumption of an extruded versus a non-extruded source.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Mycoprotein and Muscle Protein Synthetic Response

NCT04084652

Anabolic Response to Mycoprotein and Micronutrient Ingeston

COMPLETED NA

Mycoprotein as the Basis of a Sustainable Diet to Support Muscle Mass Maintenance and Reconditioning in Older Adults.

NCT04325178

Aging Sarcopenia

COMPLETED NA

The Impact of Enteral Versus Oral Protein Feeding on Muscle Protein Synthesis in Healthy Young Males and Females

NCT03571425

Healthy

COMPLETED NA

Assessing the Impact of a Leucine Enriched Whey Protein vs Isonitrogenous Whey on Muscle Protein Synthetic Responses in the Rested and Acute Post Exercise States in Older Adults

NCT06971822

Healthy Male Volunteers Over 65

RECRUITING NA

Mycoprotein, Resistance Training, and Hypertrophy

NCT03572127

Hypertrophy

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postprandial Plasma Amino Acid Availability

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dry Blend

A dry blend of mycoprotein and pea protein.

Group Type EXPERIMENTAL

Dry protein blend ingestion

Intervention Type DIETARY_SUPPLEMENT

Ingestion of protein blend powders mixed in water

Extrudate

An extruded blend of mycoprotein and pea protein

Group Type EXPERIMENTAL

Extruded protein blend ingestion

Intervention Type DIETARY_SUPPLEMENT

Ingestion of protein blend powders mixed in water

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dry protein blend ingestion

Ingestion of protein blend powders mixed in water

Intervention Type DIETARY_SUPPLEMENT

Extruded protein blend ingestion

Ingestion of protein blend powders mixed in water

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* BMI between 18 and 30.
* Metabolically healthy

Exclusion Criteria

* Any metabolic impairments
* cardio/pulmonary diseases.
* Chronic use of the over the counter medicine
* A personal or family history of epilepsy, seizures or schizophrenia.
* Allergic to mycoprotein/Quorn/edible fungi/environmental mould products.

Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes